ReviewJournal of bone oncology2026

Efficacy of immune-oncology combinations versus sunitinib in patients with bone metastases from renal cell carcinoma: A systematic review and meta-analysis of phase III trials with long-term follow-up.

Clara Fish Araujo de Albuquerque et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.